AIDS Healthcare Foundation President and Gilead Sciences stockholder Michael Weinstein has written to the Securities and Exchange Commission asking the SEC to deny Gilead's recent request to exclude a shareholder proposal submitted by Weinstein to Gilead that was intended to be included in its Proxy for shareholder vote during Gilead's 2014 Annual ... (more)
http://ift.tt/1mVFYzp
http://ift.tt/1mVFYzp
No comments:
Post a Comment